VAERS reports by lot

Pfizer COVID-19 lot GD1857: VAERS reports

177 VAERS reports list lot GD1857 as a Pfizer COVID-19 vaccine, received between 2022-11-11 and 2023-10-02. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
177
Reports
1%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1733%
Neurological1122%
Cardiac / Cardiovascular816%
Gastrointestinal510%
Musculoskeletal48%
Dermatological (non-injection-site)24%
Psychiatric / Neuropsychiatric24%
Respiratory12%
Injection-site / Local reaction12%

Where reports came from

U.S. state of the reporter, where given (top 12).

California20
Colorado12
Washington10
Maryland10
New Jersey9
Georgia9
Illinois8
Arizona6
New Mexico6
Texas6
Michigan6
Massachusetts5

Reports by month received

2022-114
2022-1247
2023-0150
2023-0218
2023-0318
2023-0415
2023-055
2023-065
2023-072
2023-084
2023-097
2023-102

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.